Heated chemo during surgery aims to stop uterine Cancer's return
NCT ID NCT04727242
First seen Dec 12, 2025 · Last updated May 25, 2026 · Updated 20 times
Summary
This study tests whether giving a dose of heated chemotherapy directly into the abdomen during surgery can lower the chance of uterine leiomyosarcoma coming back. About 17 adults with a local recurrence of this rare cancer will receive the treatment, followed by standard chemotherapy. The goal is to see if this approach improves how long patients live without the cancer progressing.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for UTERINE LEIOMYOSARCOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Stanford University
Stanford, California, 94305, United States
Conditions
Explore the condition pages connected to this study.